SCHEMBL3957456

SCHEMBL3957456

Nc1ncc(Cc2cccs2)c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727573 0.84 PIK3CD (0.43) —
SCHEMBL5727576 0.84 PIK3CD (0.43) —
SCHEMBL5726650 0.76 TP53 (0.48) —
SCHEMBL5726333 0.76 MAPT (0.41) —
SCHEMBL4462500 0.76 KDM4E (0.45) —
SCHEMBL5726244 0.75 PIK3CD (0.36) —
SCHEMBL9390272 0.73 PIK3CD (0.43) —
SCHEMBL380792 0.73 DHFR (0.67) —
SCHEMBL2719810 0.72 KDM4E (0.50) —
SCHEMBL9539329 0.72 PIK3CD (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104203939-A Diaminopyrimidines as human Respiratory Syncytial Virus (RSV) inhibitors ABBVIE INC 2014-12-10 — — CN claimed
CN-104203939-A Diaminopyrimidines as human Respiratory Syncytial Virus (RSV) inhibitors ABBVIE INC 2014-12-10 — — CN disclosed
US-7550473-B2 Pyrimidine derivatives useful as inhibitors of PKC-theta BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-06-23 — — US disclosed
US-20050124640-A1 Pyrimidine derivatives useful as inhibitors of PKC-theta BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-06-09 — — US disclosed
Send feedback